Avigan

Summary

Avigan is a pharmaceutical product^[1].

Key Facts

• Avigan is credited with the discovery of Toyama Chemical^[2].
• Avigan is in the country of Japan^[3].
• Avigan's instance of is recorded as pharmaceutical product^[4].
• Avigan's instance of is recorded as brand^[5].
• Avigan's manufacturer is recorded as Fujifilm Toyama Chemical^[6].
• +2014-00-00T00:00:00Z marks the founding of Avigan^[7].
• Avigan's time of discovery or invention is recorded as +2000-00-00T00:00:00Z^[8].
• Avigan's route of administration is recorded as oral administration^[9].
• Avigan's catalog is recorded as CAS COVID-19 Anti-Viral Candidate Compounds^[10].
• Avigan's medical condition treated is recorded as influenza^[11].
• Avigan's subject has role is recorded as antiviral agent^[12].
• Avigan's subject has role is recorded as enzyme inhibitor^[13].
• Avigan's has active ingredient is recorded as favipiravir^[14].
• Avigan's therapeutic area is recorded as influenza^[15].
• Avigan's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+1200'}^[16].
• Avigan's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+400'}^[17].

Body

Geography

Avigan is in the country of Japan^[3].

Designation and Status

Recorded instance of include pharmaceutical product^[4] and brand^[5].

History and Context

+2014-00-00T00:00:00Z marks the founding of Avigan^[7].